Off-Label Dissemination Raises Liability Issues For Industry - RPR Exec
Executive Summary
Industry should consider the liability implications of off-label dissemination, Rhone-Poulenc Rorer Associate Counsel Mark Feingold told a meeting of the Drug Information Association in New York Feb. 23.